Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard A Liebman

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Blood|December 28, 2020
Are Tpo agonists an option for ITP in pregnancy?Howard A Liebman
Clinical Advances in Hematology & Oncology : H&O|March 28, 2025
Thrombosis in immune thrombocytopeniaHoward A Liebman
Hematology. American Society of Hematology. Education Program|December 17, 2008
Immune thrombocytopenia (ITP): an historical perspectiveHoward A Liebman
Seminars in Hematology|June 18, 2016
Immune modulation for autoimmune disorders: evolution of therapeuticsHoward A Liebman
Hematology/Oncology Clinics of North America|November 26, 2009
PrefaceHoward A Liebman
Thrombosis Research|May 28, 2014
Thrombocytopenia in cancer patientsHoward A Liebman
Cancer Control : Journal of the Moffitt Cancer Center|September 24, 2005
Current perspectives on primary prophylaxis and patient risk factors for venous thromboembolism in the cancer patientHoward A Liebman
Vascular|March 1, 2008
Heparin-induced thrombocytopenia: diagnosis and managementHoward A Liebman
Thrombosis Research|April 29, 2018
Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE riskHoward A Liebman
Hematology. American Society of Hematology. Education Program|December 17, 2008
Viral-associated immune thrombocytopenic purpuraHoward A Liebman
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Blood|December 28, 2020
Are Tpo agonists an option for ITP in pregnancy?Howard A Liebman
Clinical Advances in Hematology & Oncology : H&O|March 28, 2025
Thrombosis in immune thrombocytopeniaHoward A Liebman
Hematology. American Society of Hematology. Education Program|December 17, 2008
Immune thrombocytopenia (ITP): an historical perspectiveHoward A Liebman
Seminars in Hematology|June 18, 2016
Immune modulation for autoimmune disorders: evolution of therapeuticsHoward A Liebman
Hematology/Oncology Clinics of North America|November 26, 2009
PrefaceHoward A Liebman
Thrombosis Research|May 28, 2014
Thrombocytopenia in cancer patientsHoward A Liebman
Cancer Control : Journal of the Moffitt Cancer Center|September 24, 2005
Current perspectives on primary prophylaxis and patient risk factors for venous thromboembolism in the cancer patientHoward A Liebman
Vascular|March 1, 2008
Heparin-induced thrombocytopenia: diagnosis and managementHoward A Liebman
Thrombosis Research|April 29, 2018
Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE riskHoward A Liebman
Hematology. American Society of Hematology. Education Program|December 17, 2008
Viral-associated immune thrombocytopenic purpuraHoward A Liebman
Pageof 7